Enablex Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

enablex

pharmacy retailing (nz) ltd t/a healthcare logistics - darifenacin hydrobromide 17.85mg equivalent to darifenacin 15 mg;   - modified release tablet - 15 mg - active: darifenacin hydrobromide 17.85mg equivalent to darifenacin 15 mg   excipient: calcium hydrogen phosphate hypromellose magnesium stearate opadry red 00f15613 opadry white 00f18296 opadry yellow 00f12951 purified water - enablex is indicated for the treatment of overactive bladder. symptoms of overactive bladder include urgency, urge urinary incontinence and frequency.

Enablex Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

enablex

pharmacy retailing (nz) ltd t/a healthcare logistics - darifenacin hydrobromide 8.929mg equivalent to darifenacin 7.5 mg;   - modified release tablet - 7.5 mg - active: darifenacin hydrobromide 8.929mg equivalent to darifenacin 7.5 mg   excipient: calcium hydrogen phosphate hypromellose magnesium stearate opadry white 00f18296 purified water - enablex is indicated for the treatment of overactive bladder. symptoms of overactive bladder include urgency, urge urinary incontinence and frequency.

Enablex 7.5 mg Namibia - inglese - Namibia Medicines Regulatory Council

enablex 7.5 mg

novartis south africa (pty) ltd - darifenacin hydrobromide - tablet - each tablet contains darifenacin hydrobromide equiv. to darifenacin 7,5 mg

Enablex 15 mg Namibia - inglese - Namibia Medicines Regulatory Council

enablex 15 mg

novartis south africa (pty) ltd - darifenacin hydrobromide - tablet - each tablet contains darifenacin hydrobromide equiv. to darifenacin 15,0 mg